Medtronic Completes Enrollment in Stent-Safety Study

Medtronic, Inc. announced the completion of enrollment in PROTECT, the company’s global study comparing its Endeavor drug-eluting stent (DES) to Johnson & Johnson’s Cypher DES.
MSN Money